Phenergan 50mg/ml Inj, 1ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
If you miss a dose, contact your doctor to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Avoid driving or operating heavy machinery until you know how this medication affects you, as it can cause drowsiness or dizziness.
- Avoid alcohol and other sedating medications, as they can increase drowsiness and other side effects.
- Stay hydrated to help with potential dry mouth and constipation.
- Report any unusual or severe side effects immediately.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Abnormal heartbeat (fast or slow)
Trouble controlling body movements, twitching, or changes in balance
Difficulty swallowing or speaking
Shakiness, trouble moving around, or stiffness
Feeling confused
Feeling nervous and excitable
Hallucinations (seeing or hearing things that are not there)
Mood changes
Ringing in the ears
Seizures
Unexplained bruising or bleeding
Yellowing of the skin or eyes
Changes in eyesight
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Severe breathing problems, including:
+ Slow, shallow, or troubled breathing
Low white blood cell counts, which may increase the risk of infection; seek medical help if you experience:
+ Fever
+ Chills
+ Sore throat
Other Possible Side Effects
While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:
Feeling dizzy, sleepy, tired, or weak
Blurred vision
Dry mouth
Upset stomach or vomiting
Trouble sleeping
Stuffy nose
If any of these side effects or other concerns bother you or persist, contact your doctor or seek medical attention. Remember to report any side effects to your doctor or the FDA (1-800-332-1088 or https://www.fda.gov/medwatch).
Seek Immediate Medical Attention If You Experience:
- Severe drowsiness or difficulty waking up
- Very slow or shallow breathing
- Confusion or disorientation
- Hallucinations
- Muscle stiffness, tremors, or uncontrolled movements (e.g., grimacing, tongue protrusion)
- Fever, sweating, severe muscle stiffness, and confusion (signs of Neuroleptic Malignant Syndrome)
- Pain, burning, swelling, redness, or blistering at the injection site (especially with IV administration)
- Yellowing of skin or eyes (jaundice)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, including:
+ Respiratory problems like asthma, chronic obstructive pulmonary disease (COPD), or sleep apnea (breathing difficulties during sleep).
+ Liver problems or a history of Reye's syndrome.
This list is not exhaustive, and it is crucial to discuss all your health concerns with your doctor.
To ensure safe treatment, please provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking.
Any natural products or vitamins you are using.
* Your complete medical history, including any health problems.
Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe for you to do so.
Precautions & Cautions
This medication may interfere with the accuracy of certain pregnancy tests. If you are pregnant or suspect you may be pregnant, consult your doctor to discuss the potential implications.
If you have diabetes, it is crucial to closely monitor your blood sugar levels while taking this medication. Additionally, before consuming alcohol, using marijuana or other cannabis products, or taking prescription or over-the-counter drugs that may cause drowsiness, consult your doctor to discuss potential interactions.
You may be more susceptible to sunburn while taking this medication. To minimize this risk, avoid exposure to direct sunlight, sunlamps, and tanning beds. Use protective measures such as sunscreen, clothing, and eyewear that provide adequate protection against the sun.
This medication may increase the risk of seizures, particularly in individuals with a history of seizure disorders. Consult your doctor to determine if you are at a higher risk of experiencing seizures while taking this drug.
If you have a sulfite allergy, inform your doctor, as some formulations of this medication may contain sulfites.
Older adults (65 years and older) should exercise caution when taking this medication, as they may be more prone to experiencing side effects.
If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Severe CNS depression (deep sedation, coma)
- Respiratory depression
- Hypotension
- Tachycardia
- Anticholinergic effects (dilated pupils, dry mouth, flushed skin, urinary retention, bowel paralysis)
- Seizures
- Arrhythmias
- Extrapyramidal symptoms
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive, including maintaining airway, assisting ventilation, managing hypotension, and controlling seizures. Physostigmine may be considered for severe anticholinergic symptoms. Avoid epinephrine for hypotension due to paradoxical effect.
Drug Interactions
Contraindicated Interactions
- MAO inhibitors (concurrent use or within 14 days of MAOI discontinuation)
- Other CNS depressants (e.g., opioids, barbiturates, benzodiazepines) in pediatric patients < 2 years
Major Interactions
- CNS depressants (e.g., opioids, benzodiazepines, barbiturates, alcohol, tricyclic antidepressants, general anesthetics) - increased sedation, respiratory depression, hypotension
- Anticholinergic drugs (e.g., atropine, TCAs, other antihistamines) - increased anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation)
- Dopamine agonists (e.g., bromocriptine, cabergoline) - promethazine's dopamine blocking effects may antagonize their effects
- QT-prolonging drugs (e.g., antiarrhythmics, some antipsychotics, macrolide antibiotics) - theoretical risk of additive QT prolongation
- Epinephrine (paradoxical fall in blood pressure with promethazine in overdose)
Moderate Interactions
- Antihypertensives - additive hypotensive effects
- Cholinesterase inhibitors (e.g., donepezil) - promethazine's anticholinergic effects may antagonize their effects
- Metoclopramide - additive risk of extrapyramidal symptoms
- Phenytoin - promethazine may alter phenytoin metabolism
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To identify contraindications or conditions requiring caution.
Timing: Prior to administration
Rationale: To identify potential drug interactions, especially with CNS depressants or anticholinergic agents.
Timing: Prior to administration
Rationale: To establish baseline for monitoring effects of sedation and respiratory depression.
Timing: Prior to administration
Routine Monitoring
Frequency: Every 15-30 minutes initially, then as clinically indicated (e.g., every 1-2 hours) until stable
Target: Appropriate level of sedation for indication, avoiding over-sedation
Action Threshold: Excessive sedation, unresponsiveness, difficulty arousing
Frequency: Every 15-30 minutes initially, then as clinically indicated (e.g., every 1-2 hours) until stable
Target: Age-appropriate respiratory rate, O2 saturation >92-94%
Action Threshold: Respiratory depression (<10 breaths/min in adults), shallow breathing, O2 saturation <90%
Frequency: Every 15-30 minutes initially, then as clinically indicated (e.g., every 1-2 hours) until stable
Target: Within patient's normal range
Action Threshold: Significant hypotension or bradycardia/tachycardia
Frequency: Continuously during infusion, then regularly post-infusion
Target: No signs of irritation, pain, swelling, redness, or extravasation
Action Threshold: Any signs of pain, burning, swelling, redness, or extravasation; discontinue immediately and manage extravasation.
Symptom Monitoring
- Excessive sedation
- Respiratory depression (slow, shallow breathing)
- Dizziness
- Confusion
- Dry mouth
- Blurred vision
- Urinary retention
- Constipation
- Extrapyramidal symptoms (rare: dystonia, akathisia, parkinsonism)
- Neuroleptic Malignant Syndrome (rare: fever, muscle rigidity, altered mental status, autonomic instability)
- Injection site pain, burning, swelling, redness, blistering, tissue necrosis (especially with IV administration)
Special Patient Groups
Pregnancy
Promethazine is Pregnancy Category C. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Limited human data suggest no increased risk of major birth defects, but some studies suggest a possible association with congenital malformations when used in the first trimester. Use near term may cause respiratory depression or extrapyramidal symptoms in the neonate.
Trimester-Specific Risks:
Lactation
Promethazine is excreted into breast milk. The American Academy of Pediatrics considers it to be of 'concern' due to potential for sedation and anticholinergic effects in the infant. Use with caution, monitor infant for drowsiness, irritability, or poor feeding. Avoid in preterm or jaundiced infants.
Pediatric Use
Contraindicated in patients less than 2 years of age due to the risk of fatal respiratory depression. Use with extreme caution in pediatric patients 2 years of age and older; use the lowest effective dose and avoid concomitant use of other respiratory depressants. Risk of extrapyramidal symptoms and paradoxical excitation (restlessness, agitation) is higher in pediatric patients.
Geriatric Use
Use with caution in elderly patients due to increased susceptibility to anticholinergic effects (e.g., dry mouth, blurred vision, urinary retention, constipation), sedation, dizziness, and hypotension. Start with lower doses and titrate slowly. Increased risk of falls. May exacerbate underlying conditions like glaucoma or prostatic hypertrophy.
Clinical Information
Clinical Pearls
- **Black Box Warning:** Absolutely contraindicated in children < 2 years due to fatal respiratory depression. Use extreme caution in children âĨ 2 years.
- **IV Administration:** The preferred route is deep IM injection. IV administration carries a black box warning for severe tissue injury (gangrene, necrosis) due to extravasation or intra-arterial injection. If IV is necessary, use a large, patent vein, dilute to ⤠25 mg/mL, administer slowly (no faster than 25 mg/min), and ensure the patient reports any pain or burning immediately.
- **Sedation:** Promethazine is a potent sedative. Warn patients about impaired ability to drive or operate machinery. Avoid concomitant use with alcohol or other CNS depressants.
- **Anticholinergic Effects:** Be mindful of anticholinergic side effects, especially in elderly patients or those with pre-existing conditions like glaucoma, BPH, or bowel obstruction.
- **Extrapyramidal Symptoms (EPS):** While less common than with typical antipsychotics, promethazine can cause EPS, especially at higher doses or in susceptible individuals (e.g., children).
- **Photosensitivity:** Advise patients to use sun protection as promethazine can cause photosensitivity.
Alternative Therapies
- For nausea/vomiting: Ondansetron, Metoclopramide, Prochlorperazine, Dimenhydrinate
- For allergic reactions: Diphenhydramine, Hydroxyzine, Cetirizine, Loratadine
- For sedation: Diphenhydramine, Hydroxyzine, Benzodiazepines (e.g., Lorazepam, Midazolam)
- For adjunct to analgesia: Hydroxyzine